Thrombotic events and mortality risk in patients with newly diagnosed polycythemia vera or essential thrombocythemia

Authors: Pemmaraju, Naveen, Gerds, Aaron T., Yu, Jingbo, Parasuraman, Shreekant, Shah, Anne, Xi, Ann, Kumar, Shambhavi, Scherber, Robyn M., Verstovsek, Srdan

Source: In Leukemia Research April 2022 115

Changes in the incidence and overall survival of patients with myeloproliferative neoplasms between 2002 and 2016 in the United States

Authors: Verstovsek, Srdan, Yu, Jingbo, Scherber, Robyn M., Verma, Sumit, Dieyi, Christopher, Chen, Chien-Cheng, Parasuraman, Shreekant

Source: Leukemia & lymphoma. 63(3):694-702

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100142357909.0x000001&indx=1&recIds=ETOCvdc_100142357909.0x000001

Quality of life independently predicts overall survival in myelofibrosis: Key insights from the COntrolled MyeloFibrosis Study with ORal Janus kinase inhibitor Treatment (COMFORT)‐I study

Authors: Kosiorek, Heidi E., Scherber, Robyn M., Geyer, Holly L., Verstovsek, Srdan, Langlais, Blake T., Mazza, Gina L., Gotlib, Jason, Gupta, Vikas, Padrnos, Leslie J., Palmer, Jeanne M., Fleischman, Angela, Mesa, Ruben A., Dueck, Amylou C.

Source: British journal of haematology. 198(6):1065-1068

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100165407646.0x000001&indx=1&recIds=ETOCvdc_100165407646.0x000001

Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes

Authors: Gerds, Aaron T., Yu, Jingbo, Scherber, Robyn M., Paranagama, Dilan, Kish, Jonathan K., Visaria, Jay, Singhal, Mukul, Verstovsek, Srdan, Pemmaraju, Naveen

Source: Acta haematologica. 145(4):448-453

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100156169546.0x000001&indx=1&recIds=ETOCvdc_100156169546.0x000001

Management of challenging myelofibrosis after JAK inhibitor failure and/or progression

Authors: Scherber, Robyn M., Mesa, Ruben A.

Source: In Blood Reviews July 2020 42

Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis

Authors: Ronner, Lukas ¹, Podoltsev, Nikolai ², Gotlib, Jason ³, Heaney, Mark L. ⁴, Kuykendall, Andrew T. ⁵, O'Connell, Casey ⁶, Shammo, Jamile ⁷, Fleischman, Angela G. ⁸, Scherber, Robyn M. ⁹, Mesa, Ruben ⁹, Yacoub, Abdulraheem ¹⁰, Perkins, Cecelia ³, Meckstroth, Shelby ¹¹, Behlman, Lindsey ², Chiaramonte, Matthew ⁴, Salehi, Mahta ⁶, Ziadkhanpour, Kimia ¹, Nguyen, Hellen ⁸, Siwoski, Olivia ¹⁰, Hung, Annie Kwok ⁹, Janania Martinez, Michelle ⁹, Nguyen, Jenny ⁸, Patel, Sagar ⁶, Kollipara, Revathi ⁷, Dave, Ami ⁷, Randall, Megan ⁷, Grant, Michael ⁷, Harrison, Mitchell ⁷, Fernandez Soto, Paola ⁷, Tremblay, Douglas ¹², Hoffman, Ronald ¹², Moshier, Erin ¹³, Mascarenhas, John ^{1, 12}

Source: In Blood 7 May 2020 135(19):1696-1703

Assessing Symptom Burden in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Patients

Authors: Garza, Juan, Anderson, Jane Margret, Scherber, Robyn M.

Source: In Hematology/Oncology Clinics of North America April 2020 34(2):475-489

Assessment of Quality of Life following Allogeneic Stem Cell Transplant for Myelofibrosis

Authors: Palmer, Jeanne, Kosiorek, Heidi E., Wolschke, Christine, Fauble, Veena D.S., Butterfield, Richard, III, Geyer, Holly, Scherber, Robyn M., Dueck, Amylou C., Gathany, Allison, Mesa, Ruben A., Kroger, Nicolaus

Source: In Biology of Blood and Marrow Transplantation November 2019 25(11):2267-2273

Integrative Approaches to Managing Myeloproliferative Neoplasms: the Role of Nutrition, Exercise, and Psychological Interventions

Authors: Surapaneni, Prathibha, Scherber, Robyn M.

Source: Current hematologic malignancy reports. 14(3):164-170

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100128376671.0x000001&indx=1&recIds=ETOCvdc_100128376671.0x000001

Item nonresponse on the Myeloproliferative Neoplasms Symptom Assessment Form (MPN-SAF): a comparison of missing data strategies

Authors: Mazza, Gina L., Kunze, Katie L., Langlais, Blake T., Kosiorek, Heidi E., DeWees, Todd A., Geyer, Holly L., Scherber, Robyn M., Mesa, Ruben A., Dueck, Amylou C.

Source: Leukemia & lymphoma. 60(7):1789-1795

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100084274627.0x000001&indx=1&recIds=ETOCvdc_100084274627.0x000001

This result is not displayed to guests.
Login for full access.

Primer on Advanced Mastocytosis

Authors: Scherber, Robyn M.

Source: Clinical lymphoma, myeloma & leukemia. 18(S1):S34-S37

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100092016942.0x000001&indx=1&recIds=ETOCvdc_100092016942.0x000001

Real-world patient characteristics and treatment patterns of ruxolitinib among patients with advanced essential thrombocythemia at community clinical practice

Authors: Verstovsek, Srdan, Amoloja, Theresa, Scherber, Robyn M., Yu, Jingbo

Source: Leukemia research. 110

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100154645220.0x000001&indx=1&recIds=ETOCvdc_100154645220.0x000001

Tobacco use in the Myeloproliferative neoplasms: symptom burden, patient opinions, and care.

Authors: Christensen, Sarah F.¹ (AUTHOR) safc@regionsjaelland.dk, Scherber, Robyn M.^2,3 (AUTHOR), Mazza, Gina L.⁴ (AUTHOR), Dueck, Amylou C.⁴ (AUTHOR), Brochmann, Nana¹ (AUTHOR), Andersen, Christen L.⁵ (AUTHOR), Hasselbalch, Hans C.¹ (AUTHOR), Mesa, Ruben A.² (AUTHOR), Geyer, Holly L.⁶ (AUTHOR)

Source: BMC Cancer. 6/10/2021, Vol. 21 Issue 1, p1-13. 13p.

Subject Terms: *TOBACCO use, *TUMORS, *QUALITY of life, *SYMPTOMS, *EX-smokers

Geographic Terms: PHILADELPHIA (Pa.)

Company/Entity: MAYO Clinic

Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients

Authors: Geyer, Holly L., Scherber, Robyn M., Dueck, Amylou C., Kiladjian, Jean-Jacques, Xiao, Zhijian, Slot, Stefanie, Zweegman, Sonja, Sackmann, Federico, Fuentes, Ana Kerguelen, Hernández-Maraver, Dolores, Döhner, Konstanze, Harrison, Claire N., Radia, Deepti, Muxi, Pablo, Besses, Carlos, Cervantes, Francisco, Johansson, Peter L., Andreasson, Bjorn, Rambaldi, Alessandro, Barbui, Tiziano, Vannucchi, Alessandro M., Passamonti, Francesco, Samuelsson, Jan, Birgegard, Gunnar, Mesa, Ruben A. ^*

Source: In Blood 12 June 2014 123(24):3803-3810

Targeting African American Nonsmokers to Motivate Smokers to Quit: A Qualitative Inquiry

Authors: Thomas, Janet L., Scherber, Robyn M., Stewart, Diana W.

Source: Health Education & Behavior. Oct 2010 37(5):680-693.

Peer Reviewed: Y

Page Count: 14

Descriptors: African Americans, Qualitative Research, Smoking, Focus Groups, Behavior Modification, Behavior Change, Motivation Techniques, Family Environment, Health Behavior, Beliefs

Managing MF Patients After Ruxolitinib Failure

Authors: Scherber, Robyn M.

Source: Clinical lymphoma, myeloma & leukemia. 18(S1):S11-S13

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100081396624.0x000001&indx=1&recIds=ETOCvdc_100081396624.0x000001

Impact of COVID19 Pandemic on an International MPN Patient Population: Survey Results from 1560 MPN Patients

Authors: Palmer, Jeanne M., Mead-Harvey, Carolyn ^*, Harrison, Claire, Dueck, Amylou C., Eckert, Ryan ^*, Kosiorek, Heidi E. ^*, Muxi, Pablo ^*, Pemmaraju, Naveen, Ruiz Arguelles, Guillermo ^*, Vannucchi, Alessandro M., Gupta, Vikas, Mascarenhas, John, Taylor, Kerry, Gowin, Krisstina L., Geyer, Holly L. ^*, Shimoda, Kazuya, Kiladjian, Jean-Jacques ^*, Komatsu, Norio, Kam Li Shan, Grace ^*, Abello, Virginia ^*, Gomez-Almaguer, David, Scherber, Robyn M., Jiang, Qian, Zuo, Xuelan ^*, Huberty, Jennifer ^*, Anderson, Lesley ^*, Langlais, Blake T. ^*, Brazeau, Ann ^*, Woehrle, Michelle ^*, Mauro, Michael J., Mesa, Ruben

Source: In Blood 5 November 2020 136 Supplement 1:1-3

To Treat or Not to Treat? Understanding Treatment Patterns in Patients with Lower-Risk Myelofibrosis at the Time of Enrollment in the MOST Study

Authors: Komrokji, Rami S., Stein, Brady L. ^*, Scherber, Robyn M., Kalafut, Patricia ^*, Ren, Haobo ^*, Verstovsek, Srdan

Source: In Blood 5 November 2020 136 Supplement 1:49-51

Reducing symptom burden in patients with myeloproliferative neoplasms in the era of Janus kinase inhibitors.

Authors: Mesa, Ruben A.¹ (AUTHOR) mesa.ruben@mayo.edu, Scherber, Robyn M.¹ (AUTHOR), Geyer, Holly L.¹ (AUTHOR)

Source: Leukemia & Lymphoma. Jul2015, Vol. 56 Issue 7, p1989-1999. 11p.

Subject Terms: *MYELOPROLIFERATIVE neoplasms, *JANUS kinases, *CHROMOSOMES, *MYELOFIBROSIS, *THROMBOCYTOSIS